Stock listing

Indivior Pharmaceuticals, Inc.

Selected listing: E7P · MUN · EUR · DE

Indivior Pharmaceuticals, Inc. (Munich:E7P), Health Technology. Latest release Sep 17, 2026: Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend.

E7P:MUNEURDEUpdated October 3, 2026

Ticker: Munich:E7P
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

About Indivior Pharmaceuticals, Inc.

The company specializes in developing and commercializing innovative treatments for addiction and other serious mental health conditions. Indivior's focus on improving patient outcomes positions it as a key player in the pharmaceutical industry.

Latest news from Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend

September 17, 2026

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

August 3, 2026

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast

July 23, 2026

New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization

May 20, 2026

Indivior Announces $175 Million Accelerated Share Repurchase

May 4, 2026

All Indivior Pharmaceuticals, Inc. news →

Events

Replays

Indivior Pharmaceuticals, Inc. (INDV) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 08:00 AM ET
Watch
Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 08:00 AM ET
Watch
Indivior Pharmaceuticals, Inc. (INDV) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:00 AM ET
Watch

Research Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. company profile

View the public company page for Indivior Pharmaceuticals, Inc. on 6ix.

Indivior Pharmaceuticals, Inc. news

Read company news and market updates connected to Indivior Pharmaceuticals, Inc..

Indivior Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Indivior Pharmaceuticals, Inc..